AI-generated analysis. Always verify with the original filing.
Enzon Pharmaceuticals issued a press release on March 19, 2026, announcing an extension of the expiration date for its exchange offer to holders of Series C Non-Convertible Redeemable Preferred Stock for shares of common stock, now expiring at 5:00 p.m. Eastern time on March 24, 2026, unless further extended. This provides additional time for preferred stockholders to exchange their shares.
Event Type
Disclosure
Voluntary
Variant
8-K
Regulation FD Disclosure. On March 19, 2026, the Company issued a press release announcing an extension to the expiration date for the exchange offer (the “ Off
Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release issued by Enzon Pharmaceuticals, Inc., dated March 19, 2026 (incorporate